MOTS-c + NAD+ + SS-31

Ask about this stack

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

25

authors mention this stack

6

ran the components concurrently

MOTS-c + NAD+ + SS-31 (MOTS-c + NAD+ + SS-31) appears in 25 author journeys (6 as actual concurrent use). Common goals: CHFrEF and energy support; General health, cellular energy, or anti-aging (popular 14-week protocol); General peptide protocol discussion regarding dosing efficiency.. Typical doses reported: NAD+ 100mg, SS-31 4mg, MOTS-c 5mg. Reported side effects include: None

Typical doses reported

Community-reported doses are not medical guidance.

How people are running it

12

Planning to run

7

Recommended / discussed

3

Currently running

3

Ran in the past

What people use it for

CHFrEF and energy supportGeneral health, cellular energy, or anti-aging (popular 14-week protocol)General peptide protocol discussion regarding dosing efficiency.General health / wellnessenergy and enduranceMitochondrial health and workout optimization

Sample reported outcomes

  • None
  • Still hitting personal records (PRs) regularly with progressive overload.
  • Felt consistently alert throughout the day with no afternoon fatigue
  • Unclear, but noted injection site reactions
  • Experienced bloating and GI discomfort from a single test dose of Betaine Anhydrous
  • synergistic effects
  • Seriously helped with ADD, leading to lowering/titrating off Vyvanse. NAD+ gave off-the-chain energy and focus for the first 4 hours.
  • Not yet started at the time of the post.

Self-reported community experiences, not verified results.

Sample reported side effects

  • None
  • Shortness of breath during heavy workouts (compound lift days like legs/back) with MOTS-C; mild injection site pain/sting.
  • Allergic reaction (itchy face/nose)
  • Developed subcutaneous non-painful nodules at the injection site (unsure if caused by NAD+ or SS-31)
  • Bloating and GI discomfort
  • None reported.
  • Skin/body tingles from NAD+, burning sensation from MOTS-C injection